Literature DB >> 2391438

Optimized procedures for the coupling of proteins to liposomes.

H C Loughrey1, L S Choi, P R Cullis, M B Bally.   

Abstract

A general, optimized method for coupling proteins to liposomes is presented. This procedure utilizes streptavidin covalently coupled to liposomes to allow the subsequent attachment of a variety of biotinated proteins of interest. In the first part of this study, covalent methods for coupling proteins to liposomes which contain the lipid derivatives MPB-PE and PDP-PE were examined. The maleimide lipid derivative MPB-PE was found to allow more efficient coupling. Thin layer chromatography however revealed that during the standard synthesis of MPB-PE, an impurity was generated which can constitute 40% or more of the derivatized PE. An improved method for the synthesis and isolation of pure MPB-PE is presented here. Subsequently, optimized conditions for the covalent coupling of streptavidin to liposomes containing pure MPB-PE were determined. The flexibility of the streptavidin-liposome system for the preparation of various types of ligand bearing liposomes is demonstrated by the rapid association of a variety of biotinated proteins to streptavidin-liposome systems. The ability of these conjugates to target to specific cell populations in vitro as directed by defined biotinated monoclonal antibodies is demonstrated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391438     DOI: 10.1016/0022-1759(90)90394-b

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Selective modulation with liposomes containing Der. P1 labelled with monoclonal antibodies.

Authors:  G P Rombi; G Piu
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

2.  Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.

Authors:  E Harokopakis; G Hajishengallis; S M Michalek
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 3.  Leukocytes as carriers for targeted cancer drug delivery.

Authors:  Michael J Mitchell; Michael R King
Journal:  Expert Opin Drug Deliv       Date:  2014-10-01       Impact factor: 6.648

4.  Antigenic Liposomes for Generation of Disease-specific Antibodies.

Authors:  Kyle J Bednar; Lakeya Hardy; Johanna Smeekens; Dharmendra Raghuwanshi; Shiteng Duan; Mike D Kulis; Matthew S Macauley
Journal:  J Vis Exp       Date:  2018-10-25       Impact factor: 1.355

5.  Constant pressure-controlled extrusion method for the preparation of Nano-sized lipid vesicles.

Authors:  Leslie A Morton; Jonel P Saludes; Hang Yin
Journal:  J Vis Exp       Date:  2012-06-22       Impact factor: 1.355

6.  Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses.

Authors:  J S Remy; A Kichler; V Mordvinov; F Schuber; J P Behr
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Carbohydrate-dependent binding of human myeloid leukemia cell lines to neoglycoenzymes, matrix-immobilized neoglycoproteins, and bone marrow stromal cell layers.

Authors:  S Gabius; R Wawotzny; U Martin; S Wilholm; H J Gabius
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

8.  A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo.

Authors:  S A Longman; P R Cullis; L Choi; G de Jong; M B Bally
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis.

Authors:  Matthew S Macauley; Fabian Pfrengle; Christoph Rademacher; Corwin M Nycholat; Andrew J Gale; Annette von Drygalski; James C Paulson
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

10.  Steric and not structure-specific factors dictate the endocytic mechanism of glycosylphosphatidylinositol-anchored proteins.

Authors:  Pinkesh Bhagatji; Rania Leventis; Jonathan Comeau; Mohammad Refaei; John R Silvius
Journal:  J Cell Biol       Date:  2009-08-17       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.